tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CATX Stock Latest News

Perspective Therapeutics Updates Strategic Focus on Radiopharmaceuticals
Company AnnouncementsPerspective Therapeutics Updates Strategic Focus on Radiopharmaceuticals
16d ago
8K
CATX
Perspective Therapeutics management to meet with Piper Sandler
PremiumThe Fly
Perspective Therapeutics management to meet with Piper Sandler
17d ago
CATX
Buy Rating for Perspective Therapeutics: Clinical Advancements and Strategic Developments Drive Positive Outlook
PremiumRatings
Buy Rating for Perspective Therapeutics: Clinical Advancements and Strategic Developments Drive Positive Outlook
24d ago
CATX
Perspective Therapeutics Advances Phase 1/2a Clinical Trial
PremiumCompany Announcements
Perspective Therapeutics Advances Phase 1/2a Clinical Trial
26d ago
8K
CATX
Perspective Therapeutics price target raised to $12 from $9 at B. Riley
PremiumThe Fly
Perspective Therapeutics price target raised to $12 from $9 at B. Riley
26d ago
CATX
Optimistic Buy Rating for Perspective Therapeutics Driven by Strategic Developments and Promising Clinical Data
PremiumRatingsOptimistic Buy Rating for Perspective Therapeutics Driven by Strategic Developments and Promising Clinical Data
27d ago
CATX
Perspective Therapeutics commences recruitment for 212PbVMT-alpha-NET
Premium
The Fly
Perspective Therapeutics commences recruitment for 212PbVMT-alpha-NET
27d ago
CATX
Perspective Therapeutics Updates on Radiopharmaceutical Advancements
Premium
Company Announcements
Perspective Therapeutics Updates on Radiopharmaceutical Advancements
2M ago
8K
CATX
Perspective Therapeutics price target raised to $16 from $15 at RBC Capital
PremiumThe Fly
Perspective Therapeutics price target raised to $16 from $15 at RBC Capital
2M ago
CATX
Promising Clinical Trial Results and Safety Profile Drive Buy Rating for Perspective Therapeutics
PremiumRatings
Promising Clinical Trial Results and Safety Profile Drive Buy Rating for Perspective Therapeutics
2M ago
CATX
Promising Clinical Updates and Strong Safety Profile Support Buy Rating for Perspective Therapeutics
PremiumRatings
Promising Clinical Updates and Strong Safety Profile Support Buy Rating for Perspective Therapeutics
2M ago
CATX
Perspective Therapeutics Reports Promising Trial Results for [212Pb]VMT-α-NET
PremiumCompany Announcements
Perspective Therapeutics Reports Promising Trial Results for [212Pb]VMT-α-NET
2M ago
8K
CATX
Perspective Therapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsPerspective Therapeutics Holds Annual Stockholders Meeting
2M ago
8K
CATX
Buy Rating on Perspective Therapeutics: Promising Clinical Data, Strategic Advancements, and Strong Financial Position
Premium
Ratings
Buy Rating on Perspective Therapeutics: Promising Clinical Data, Strategic Advancements, and Strong Financial Position
2M ago
CATX
Optimistic Buy Rating for Perspective Therapeutics Amid Financial Stability and Promising Clinical Developments
Premium
Ratings
Optimistic Buy Rating for Perspective Therapeutics Amid Financial Stability and Promising Clinical Developments
2M ago
CATX
Perspective Therapeutics Reports Q1 2025 Earnings
PremiumCompany Announcements
Perspective Therapeutics Reports Q1 2025 Earnings
2M ago
CATX
Buy Rating for Perspective Therapeutics: Strong Financials and Promising Clinical Progress
PremiumRatings
Buy Rating for Perspective Therapeutics: Strong Financials and Promising Clinical Progress
2M ago
CATX
Perspective Therapeutics Reports Q1 2025 Results and Updates
PremiumCompany Announcements
Perspective Therapeutics Reports Q1 2025 Results and Updates
2M ago
8K
CATX
Buy Rating for Perspective Therapeutics: Promising Advancements in Targeted Radioligand Therapy
PremiumRatings
Buy Rating for Perspective Therapeutics: Promising Advancements in Targeted Radioligand Therapy
3M ago
CATX
Perspective Therapeutics announces first patient dosed with PSV359
PremiumThe FlyPerspective Therapeutics announces first patient dosed with PSV359
3M ago
CATX
Perspective Therapeutics management to meet with Truist
Premium
The Fly
Perspective Therapeutics management to meet with Truist
3M ago
CATX
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
Premium
Market News
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
3M ago
CATX
INDI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >